Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Lentiviral vector containing the human Wiskott Aldrich syndrome protein gene

EU orphan designation number: EU/3/05/345
Active ingredient: Lentiviral vector containing the human Wiskott Aldrich syndrome protein gene
Indication: Treatment of Wiskott-Aldrich syndrome
Sponsor: Généthon
1 bis rue de l’internationale, 91000 Evry, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/01/2006 Orphan designation EMEA/OD/087/05 (2006)208 of 24/01/2006
02/05/2014 Removal of orphan designation from Community Register